Literature DB >> 10678841

Cholesterol and strokes. Cholesterol lowering is indicated for strokes due to carotid atheroma.

M F Oliver.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678841      PMCID: PMC1127514          DOI: 10.1136/bmj.320.7233.459

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  15 in total

1.  Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.

Authors:  K Yano; D M Reed; C J MacLean
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

2.  Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

Authors:  J F Plehn; B R Davis; F M Sacks; J L Rouleau; M A Pfeffer; V Bernstein; T E Cuddy; L A Moyé; L B Piller; J Rutherford; L M Simpson; E Braunwald
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

3.  Natural statins and stroke risk.

Authors:  C D Furberg
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

4.  Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors.

Authors:  G J Blauw; A M Lagaay; A H Smelt; R G Westendorp
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

5.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

6.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

7.  Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

Authors: 
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

8.  Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.

Authors:  W H Ettinger; P W Wahl; L H Kuller; T L Bush; R P Tracy; T A Manolio; N O Borhani; N D Wong; D H O'Leary
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

Authors: 
Journal:  Lancet       Date:  1994-09-03       Impact factor: 79.321

View more
  3 in total

1.  Statins for stroke should be considered in biologically fit people over 75.

Authors:  J Kelly; A Rudd
Journal:  BMJ       Date:  2000-05-06

Review 2.  Place of drug therapy in the treatment of carotid stenosis.

Authors:  Norberto Andaluz; Mario Zuccarello
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Could targeted food taxes improve health?

Authors:  Oliver Mytton; Alastair Gray; Mike Rayner; Harry Rutter
Journal:  J Epidemiol Community Health       Date:  2007-08       Impact factor: 3.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.